(Q69908543)

English

A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension

scientific article published on 01 January 1985

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

hydrochlorothiazide

1 reference

based on heuristic

inferred from title

author name string

E van der Veur

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

B S ten Berge

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

A J Donker

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

J F May

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

F H Schuurman

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

H Wesseling

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 January 1985

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

507-511

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899671%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00544059

0 references

Prescribing prazosin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of prazosin and phenoxybenzamine on arterial blood pressure, heart rate, and plasma catecholamines in essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled comparison of labetalol and propranolol in the management of severe hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of prazosin in patients with hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Labetalol in long-term treatment of hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemodynamic changes in long-term diuretic therapy of essential hypertension. A comparative study of chlorthalidone, polythiazide and hydrochlorothiazide

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiological mechanisms in essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of labetalol on continuous ambulatory blood pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Labetalol in resistant hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha and beta adrenergic blockade in hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of hypertension with labetalol

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with labetalol in hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihypertensive action of drug combination: polythiazide, prazosin and tolamolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A long-term study of labetalol in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with prazosin in the treatment of patients with severe hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemodynamic consequences of long-term beta-blocker therapy: a 5-year follow-up study of atenolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3899671

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69908543&oldid=1754757094"